This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase II, open-label study of PTK787/ZK222584 in...
Clinical trial

A Phase II, open-label study of PTK787/ZK222584 in the treatment of metastatic gastrointestinal stromal tumors GISTs resistant to imatinib mesylate

Read time: 1 mins
Last updated:15th Mar 2007
To determine safety and tolerability and efficacy of chronic oral administration of PTK787/ZK222584 in the treatment of imatinib-resistent GISTs
Category Value
Study start date 2007-03-15

View full details